New antibody treatment tested to keep bone cancer from coming back
NCT ID NCT02502786
Summary
This study is testing whether a combination of an antibody called Hu3F8 and a drug called GM-CSF can help keep patients with recurrent osteosarcoma (a type of bone cancer) in remission longer and prevent the cancer from returning. The trial involves 46 participants aged 1 to 40 who have had their cancer come back but are currently in remission after surgery. Researchers will measure how long patients remain cancer-free after receiving this treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Los Angeles (Data Collection Only)
Los Angeles, California, 90027, United States
-
MD ANDERSON CANCER CENTER (Data Collection Only)
Houston, Texas, 77030, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.